FORA Capital’s Medifast MED Stock Holding History

FORA Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,397	Closed	-$352K	–	507
2023 Q1	$352K	Buy	3,397 +1,460	+75%	+$162K	0.04%	412
2022 Q4	$223K	Buy	+1,937	New	+$226K	0.04%	426
2020 Q4	–	Sell	-281	Closed	-$46K	–	1048
2020 Q3	$46K	Buy	+281	New	+$46.3K	0.03%	449

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FORA Capital's MED Position: Q2 2023 in Review

FORA Capital sold out of Medifast (MED) in Q2 2023, closing a stake of 3,397 shares — an estimated $352K sold.

FORA Capital first reported a position in MED in Q3 2020 and held it in 3 quarters. The position peaked at $352K in Q1 2023. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

FORA Capital reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
FORA Capital sold 3,397 Medifast shares in Q2 2023, an estimated $352K.
FORA Capital first reported a position in Medifast in Q3 2020 and held it in 3 quarters.
FORA Capital's Medifast position peaked at $352K in Q1 2023.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on FORA Capital's 13F filing for Q2 2023, filed 11 Aug 2023.